Part 312 - INVESTIGATIONAL NEW DRUG APPLICATION
- Subpart A - GENERAL PROVISIONS (§§ 312.1 — 312.10)
- Subpart B - INVESTIGATIONAL NEW DRUG APPLICATION (IND) (§§ 312.20 — 312.38)
- Subpart C - ADMINISTRATIVE ACTIONS (§§ 312.40 — 312.48)
- Subpart D - RESPONSIBILITIES OF SPONSORS AND INVESTIGATORS (§§ 312.50 — 312.70)
- Subpart E - DRUGS INTENDED TO TREAT LIFE-THREATENING AND SEVERELY-DEBILITATING ILLNESSES (§§ 312.80 — 312.88)
- Subpart F - MISCELLANEOUS (§§ 312.110 — 312.145)
- Subpart G - DRUGS FOR INVESTIGATIONAL USE IN LABORATORY RESEARCH ANIMALS OR IN VITRO TESTS (§ 312.160)
- Subpart I - EXPANDED ACCESS TO INVESTIGATIONAL DRUGS FOR TREATMENT USE (§§ 312.300 — 312.320)